Paper42921135PubMed
Tumor-associated macrophages in glioblastoma: implications for immunotherapy.
Lei J and 8 others. Front Immunol, 2026.
Cite this record
ConductScience Library. Tumor-associated macrophages in glioblastoma: implications for immunotherapy. Papers, record 42921135. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42921135
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumor-associated macrophages in glioblastoma: implications for immunotherapy.
- Journal
- Front Immunol
- Year
- 2026
- Publication types
- Journal Article, Review, Research Support, Non-U.S. Gov't
- Revised in PubMed
- 2026-10-27
Source PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioblastoma | Major topic |
| Tumor-Associated Macrophages | Major topic |
| Brain Neoplasms | Major topic |
| Immunotherapy | Major topic |
| Humans | |
| Tumor Microenvironment | |
| Animals |
Source PubMed
References109
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38633388 | Co-expression of immune checkpoints in glioblastoma revealed by single-nucleus RNA sequencing and spatial transcriptomics. | Comput Struct Biotechnol J | 2024 | https://conductscience.org/library/papers/38633388 | PubMed |
| 2 | 40424600 | Polyamine acetylation mediates crosstalk between cancer cells and myeloid cells to promote mesenchymal/plurimetabolic states in glioblastoma. | Neuro Oncol | 2025 | https://conductscience.org/library/papers/40424600 | PubMed |
| 3 | 39928563 | The AURKA inhibitor alters the immune microenvironment and enhances targeting B7-H3 immunotherapy in glioblastoma. | JCI Insight | 2025 | https://conductscience.org/library/papers/39928563 | PubMed |
| 4 | 39631850 | Co-evolution of glioma and immune microenvironment. | J Immunother Cancer | 2024 | https://conductscience.org/library/papers/39631850 | PubMed |
| 5 | 39729678 | Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour group. | Eur J Cancer | 2025 | https://conductscience.org/library/papers/39729678 | PubMed |
| 6 | 41783996 | Spatial transcriptomics characterisation of radionecrotic changes in glioblastoma patients. | Neuro Oncol | 2026 | https://conductscience.org/library/papers/41783996 | PubMed |
| 7 | 36841424 | CAR T-cells to treat brain tumors. | Brain Res Bull | 2023 | https://conductscience.org/library/papers/36841424 | PubMed |
| 8 | 39068459 | Decoding the spatiotemporal heterogeneity of tumor-associated macrophages. | Mol Cancer | 2024 | https://conductscience.org/library/papers/39068459 | PubMed |
| 9 | 40800581 | New Insights into Monocyte-Derived Macrophages in Glioblastoma. | Research (Wash D C) | 2025 | https://conductscience.org/library/papers/40800581 | PubMed |
| 10 | 34145435 | Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics. | Nat Rev Genet | 2021 | https://conductscience.org/library/papers/34145435 | PubMed |
| 11 | 42121941 | Microglia Reprogramming in Glioblastoma: Stem Cell-Derived Factors as Emerging Immunomodulators. | Cells | 2026 | https://conductscience.org/library/papers/42121941 | PubMed |
| 12 | 40940872 | Choice of Animal Models to Investigate Cell Migration and Invasion in Glioblastoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40940872 | PubMed |
| 13 | 41992007 | Spatial and single-cell characterization of human glioblastoma tumor microenvironment reveals malignant cellular communities. | Nat Neurosci | 2026 | https://conductscience.org/library/papers/41992007 | PubMed |
| 14 | 39626657 | V-domain immunoglobulin suppressor of T-cell activation and programmed death receptor 1 dual checkpoint blockade enhances antitumour immunity and survival in glioblastoma. | Br J Pharmacol | 2025 | https://conductscience.org/library/papers/39626657 | PubMed |
| 15 | 37738997 | Primary brain tumours in adults. | Lancet | 2023 | https://conductscience.org/library/papers/37738997 | PubMed |
| 16 | 39097091 | IRnet: Immunotherapy response prediction using pathway knowledge-informed graph neural network. | J Adv Res | 2025 | https://conductscience.org/library/papers/39097091 | PubMed |
| 17 | 41903687 | Dual-targeting zein janus nanoparticles reprogram tumor-associated macrophages for enhanced glioblastoma therapy. | Nanomedicine | 2026 | https://conductscience.org/library/papers/41903687 | PubMed |
| 18 | 41175739 | Small-molecule therapies targeting tumor-associated macrophages in glioma: mechanisms and potential. | Int Immunopharmacol | 2026 | https://conductscience.org/library/papers/41175739 | PubMed |
| 19 | 41515934 | The Myeloid Biomarker MS4A6A Drives an Immunosuppressive Microenvironment in Glioblastoma via Activation of the PGE2 Signaling Axis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41515934 | PubMed |
| 20 | 41414954 | The Immunosuppressive Microenvironment of Glioblastoma: Mechanisms, Clinical Challenges and Future Directions. | Immunology | 2026 | https://conductscience.org/library/papers/41414954 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42921135
GET https://conductscience.org/api/papers/v1/42921135/references?page=2